Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2025-12-24 @ 7:32 PM
NCT ID:
NCT05672303
Eligibility Criteria:
Inclusion Criteria:
* 28-36 gestational week
* No congenital malformation
* follow up with a diagnosis of respiratory distress syndrome,
* receive oxygen support with a nasal cannula or tube,
* not receive mechanical ventilation support,
* no contraindications for hepatitis B vaccine administration,
* stable vital signs before vaccination,
* not receive analgesic sedation treatment
* whose parents give verbal and written consent to participate in the study.
Exclusion Criteria:
* Infants of parents who did not give informed voluntary consent will not be included in the study.
* Decreased oxygen saturation levels
* Tachycardia just before the vaccine administration
* Invasive intervention in the right hand.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
28 Weeks
Maximum Age:
36 Weeks
Study:
NCT05672303
Study Brief:
Protocol Section:
NCT05672303